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OESTROGENS promote keratinisation in specific organs rather than generally
as does vitamin A insufficiency (Gitlin, 1957), suppress the formation of mixed
carcinomas of the uterine cervix in mice (Glucksmann and Cherry, 1962), and
promote differentiation in the form of keratinisation in cervical tumours of mice
(Klavins and Kaufman, 1962). This enhancement ofkeratinisation by oestrogens
might be useful in the treatment of tumours refractory to radiation which often
fail to respond to treatment with increased differentiation. This may be particu-
larly useful for the mixed carcinomas of cervix which have given very poor results
for both radiotherapy and surgery. On the other hand, oestrogens stimulate
proliferation ofthe epithelium and stroma ofthe female genital tract, an effect that
might be harmful to the patient ifproduced in tumours at these sites.
The effect of castration, and of additional treatments with oestrogens, pro-
gesterone and testosterones have been studied experimentally mainly on mice
and have yielded results varying with strain ofmice, dosage and type ofcarcinogen,
dosage and type of solvent for the sex hormones. Prolonged administration of
oestrogens is followed infrequently by cervical tumours in mice (Gardner, 1959;
Murphy, 1961), but in these experiments cholesterol pellets have been used as
carriers and cholesterol itself induces cancers. Oestrogen treatment causes septic
pyometra which may promote tumour formation, so that oestrogenic hormones
may act only indirectly as carcinogenic agents (Gardner, 1953). Administration
of oestrogens in combination with chemical carcinogens neither shortens the
induction period nor increases the yield of cancers in intact mice (Murphy, 1961;
Klavins and Kaufman, 1962; Laffargue, Samso, Luscan and Francois, 1963;
Blanzat, Hirai and Pincus, 1966). In castrate mice treated with methylcholan-
threne for 4 weeks only, subsequent administration of a diethylstilboestrol-
cholesterol pellet has increased the production of tumours and this effect was
greater for a 33 % than for a 10 % hormone content of the pellet. The greater
incidence ofpyometra in mice treated with a 33 % as opposed to a 10% oestrogenic
pellet may account for the higher incidence of carcinomas (Murphy, 1961).
Oestrogens do not alter the yield of cancers in spayed mice given full carcinogenic
treatment by the thread method or painting. Taki (1967) reports an approxi-
mately equal stimulation of cancer production in castrate mice by the additional
application of cholesterol alone, oestradiol in cholesterol and oestradiol only, ifthe
treatment and observation period is limited to 5 weeks.
* Gibb Senior Fellow of the British Empire Cancer Campaign for Research.
t Working with a grant from the British Empire Cancer Campaign for Research.A. GLUCKSMANN AND CORA P. CHERRY
Injections of oestradiol dipropionate have no effect on tumour incidence in
castrate mice treated with methylcholanthrene threads (Kaslaris and Jull, 1962;
Laffargue et al., 1965). In intact mice Meisels (1964) reports prolongation of the
induction period in animals given additional oestradiol injections as compared
with those treated with a DMBA-thread only, but no difference in incidence of
cervical tumours.
Murphy (1961) finds that castration makes mice more susceptible to limited
carcinogenic exposure but detects no difference between castrates and intacts for
" full " treatment either by painting of the genital tract or insertion of a thread.
Other authors (Krieg and Reagan, 1961; Laffargue et al., 1965; Taki, 1967; Islam
and Zaman, 1965; Alauddin and Zaman, 1967; Mueenuddin and Zaman, 1967)
report at most an initially faster carcinogenesis in castrate than in intact mice.
Mice castrated at 3 to 5 weeks respond with a greater incidence ofcarcinomas and
of sarcomas of the cervico-vaginal tract than those spayed at 4 to 6 months
(Kaslaris and Jull, 1962), but no difference is found between virgin mice and those
with repeated pregnancies (Sedlis and Stone, 1965). No significant difference in
duration ofinduction time or incidence ofcarcinomas has been found in intact and
castrate mice painted with DMBA in acetone, though the type of resulting
carcinoma was altered in spayed as compared with intact animals (Glucksmann
and Cherry, 1962). Thus apart from Murphy's finding in castrate mice treated
with a carcinogen for 4 weeks only, there is no clear evidence of an enhancing
effect of oestrogens on the induction of cervical cancers. The interpretation of
Murphy's findings is complicated by his use of cholesterol as vehicle for the
oestrogen and by the induction ofpyometra with the higher dose ofdiethylstilbo-
estrol. The rapid response of the cervicovaginal tract in mice to carcinogenic
hydrocarbons, makes them unsuitable for experimentation on the effect of
castration and additional administration of sex hormones.
In rats marked and highly significant differences in the duration ofthe induction
period and in the incidence of cancers have been reported previously (Glucksmann
and Cherry, 1958; Cherry and Glucksmann, 1960), though the majority of the
induced tumours are sarcomas. Castration reduces the incidence of sarcomas to
one third of that in intact rats and additional treatment with oestrogen or pro-
gesterone has failed to increase the tumour incidence significantly. The present
communication deals with the effect of castration, that of oestrogenic treatments
at different levels of dosage and means of administration, with the effect of
testosterone and ofprogesterone treatment ofintact and castrate animals painted
once weekly with a potent carcinogen throughout their life span.
MATERIAL AND METHODS
Hooded rats of the Lister strain, random bred within a closed colony since
1940, were used for the experiments which extended over a period from 1955 to
1966. During this time the incidence of " spontaneous " tumours and other
lesions in untreated animals changed as discussed in the relevant section on
controls. Some of the experimental procedures were repeated after various
intervals and even after 10 years gave essentially the same results.
The rats were housed 7 to a cage, and given water and food pellets ad libitutm.
For certain experiments substances were dissolved and administered in the
drinking water. Only rats surviving for at least 120 days after starting an
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experiment, i.e. the induction period for the first tumours, were considered at risk.
A total of 401 animals fell into this category and an additional 76 controls were
allowed to complete their natural life span. All animals were examined at
weekly intervals and vaginal smears obtained when desirable. Sick individuals
and those with clinical or cytological signs of tumours were killed, a post mortem
performed and in addition to the organs ofthe genital tract from ovary to vulva,
the following organs were fixed for histological examination: pituitary, thyroid,
thymus, salivary glands, lungs, liver, spleen, kidneys, adrenals, intestine, mesen-
teric and lumbar lymph nodes. The material was fixed in Zenker-acetic, Bouin's
or Susa solution, embedded in paraffin after dehydration, sectioned at 6 or 8It
depending on the organ and stained with haematoxylin-eosin, van Gieson,
carmalum-orange G-aniline blue, Southgate's mucicarmine or the periodic acid-
Schiff technique after diastase digestion.
Bilateral ovariectomy was performed with a dorsal approach on rats aged
about 4 weeks. The carcinogen 9,10-dimethyl-1,2-benzanthracene (DMBA) as a
1 % solution in acetone was applied at weekly intervals when castrate or intact
rats were 2 months old. The solution was administered by means of a cotton
wool swab mounted on athinwire rodwhich was insertedinto thevagina stretched
open by dorsal flexion ofthe tail. By a rotary motion the DMBA was distributed
over the cervix, the vaginal walls and inevitably also the vulval region of the
introitus. The number of animals thus treated with and without additional
hormonal applications is given in Table I. As controls 12 intact and 8 castrate
females were painted with acetone only. Like similarly treated mice (Murphy,
1961; v. Haam and Scarpelli, 1955) they failed to produce any tumours in the
genital tract.
Additional oestrogenic treatment was given by (1) adding 0.1 mg. Stilboestrol
B.P. to 1000 ml. ofdrinking water, thus dosing each rat with about 2,ug. per day.
This addition was given continuously in some experiments (Table I) and in others
on 3 days a week (Monday, Tuesday and Wednesday) only. In the intermittent
administration rats restricted their water intake for the first 2 days as they did
not like the mixture, but were forced by their thirst to drink on the third. In this
experiment the weekly dosage was probably only about 2,g./week and not the
estimated 6,tg. as given in the Table; (2) 2 intramuscular injections per week of
1.5,tg. ofoestradiol monobenzoate (Organon) in olive oil; (3) subcutaneous implant
of a 10 mg. pellet of fused oestradiol monobenzoate (Organon); (4) subcutaneous
implant of a pellet consisting of 1 mg. oestradiol monobenzoate and 9 mg. choles-
terol (Organon). As controls a group of rats were treated with a 10 mg. pellet of
cholesterol.
Progesterone (Progestin, Organon) was administered by intramuscular injection
in a dose of 1 mg. twice weekly.
Testosterone propionate (Ciba) was applied as subcutaneous implant of a 30 mg.
pellet, followed by 3 injections of 25 mg. each of microcrystalline Testosterone
propionate (Ciba) at intervals of 2 months.
Combined treatments.-(a) oestrogens plus progesterone: rats were injected i.m.
once weekly with 3,tg. ofoestradiol monobenzoate (Organon) in olive oil and once
weekly i.m. with 1 mg. of Progesterone.
(b) oestrogens plus testosterone: Testosterone pellets of 30 mg. were implanted
3 times at intervals of 2 months and stilboestrol (0.1 mg./1000 ml.) was added
continuously to the drinking water.
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The number of animals at risk and the doses of the additional treatments are
given in Table I. The weekly dosage of 6,tg. for the intermittent stilboestrol
administration represents the maximum the animals could have had. In practice
the dose may not have exceeded 2,ug./week.
TABLE I.-Treatment Groups,
No. of
Status rats
* 43
36
° 21
21
22
23
16
11
20
17
* 21
* 27
21
* 21
* 21
2! 20
Ns
Additional
treatment
None
None
Oestrogens
Progesterone
Testosterone
20
umber of Rats at Risk and Weekly Dosages
Form of Dosage
administration per week
Stilboestrol in H20 per os
idem
idem
idem
Oestradiol monobenzoate, i.m.
,, pellet, s.c.
+ cholesterol pellet s.c.
Cholesterol pellet alone 10 mg. s.c.
Progestin i.m.
idem
idem
+ oestradiol i.m.
Testosterone propionate s.c.
idem
idem
+ stilboestrol in H20
idem
+ stilboestrol in H20
14/,g.
6,ug.
14 ug.
6 ,ug.
3,ug.
350 ,ug.
35 4jg.
2 mg.
2 mg.
1 mg.
3 mg.
1-6 mg.
1-6 mg.
1-6 mg.
14,pg.
1* 6mg.
14 4ug.
RESULTS
Control animals
Since hormonal treatments affect tumour incidence in rats and since old rats
are subject to endocrine tumours (Russfield, 1966) without additional treatment,
it is necessary to analyse tumour incidence and other changes in control animals.
As general controls groups of intact and castrate rats born at different times
were allowed to survive their natural life span and the incidence of spontaneous
tumours and of other lesions was determined. Special controls were intact or
castrate females whose genital tract was painted once weekly with acetone, and
another group of intact females whose dorsal skin was painted 4 times at weekly
intervals with a 1 % solution ofDMBA in acetone. This procedure was adopted to
test whether DMBA application influenced the incidence of spontaneous tumours.
A further group of 13 females were implanted with a 10 mg. pellet of oestradiol
monobenzoate subcutaneously, but received no other treatment. All ofthem had
to be killed after 160 days because of purulent pyometra.
General controls.-The first group of 16 intact females born in April 1955
survived for a median period of 744 days (Table II). The relevant post mortem
findings were listed as otitis media and labyrinthitis, bronchopneumonia, ileo-
caecal lesion which presented as marked dilatation ofthe ileo-caecal junction with
accumulation of faeces, ulceration of the intestinal wall and enlargement and
colliquative degeneration of the adjacent lymph nodes. To some extent the
ileo-caecal lesion resembles mesenteric disease in mice (Dunn, 1954). The breast
tumour was a large fibro-adenoma, the uterine lesion a deciduoma. There were
also 2 ovarian tumours in this group, but no leukaemias.CERVICO-VAGINAL TUMOUR INDUCTION IN RATS 549
Of 40 females born in October 1964, 20 were left intact and 20 were ovari-
ectomised when 4 weeks old. The first and last dates for death and the median
survival period are given in Table II. The castrates had a shorter median survival
TABLE II.-Morbidity of Control Animnls
General controls Special controls
, A A, A ~ ~~~~~ A
Number and sex . . 16? 20 20 Y . 12? 8 20
Additional treatment . None None None . Acetone painting of 4 x DMBA
vagina to skin in
3 weeks
Born . 1955 1964 1964 . 1956 1956 1954
29/4 20/10 20/10 . 25/3 27/11 12/8
Survival in days:
Range . . . . 189-886 322-765 260-772 . 121-385 147-465 135-803
Median . 744 749 675 . 384 457 470
Number with labyrinthitis . 2 2 0 . 2 2 4
Bronchopneumonia . 5 9 7 . 0 0 7
Ileo-caecal lesion . . . 7 3 3 6 0 14
Leukaemia . . 0 5 5 . 0 0 0
Breast tumours . . 1 2 0 . 1 0 2
Uterine tumours . . . 1 1 0 0 0 1
period than the intact animals. The ileo-caecal lesion occurred with the same
frequency in intact and spayed rats and was very much milder than in the group
born in 1955: the dilatation was only slight, ulceration less extensive and the
adjacent lymph nodes were enlarged but did not undergo colliquative necrosis.
In each group 5 leukaemias were found. This lesion started apparently in
mesenteric nodes, spread to the lymphatic tissue ofthe intestine, to the spleen and
pancreas, and involved all pelvic and abdominal organs, the lung, mediastinal and
cervical nodes and those associated with the thymus which was usually free ofthe
disease. Deposits were found also in the pituitary, ovary and adrenals. In
addition one castrate and one intact rat had a haemangioma in a mesenteric node.
In the intact animals one of the breast tumours was an adenocarcinoma and the
other a fibroadenoma. The uterine tumour was an adenocarcinoma. In addition
to the findings listed in Table II the following lesions were noted: pituitary
adenomas in 7, solid adenomas of the thyroid in 8, and cortical adenomas of the
adrenals in 9 intact rats. Terminal bronchopneumonia was found in most
animals, but was pronounced in 9.
In the spayed animals breast and uterine tumours were not seen; pituitary
adenomas occurred in 11, solid adenomas ofthe thyroid in 4, cortical adenomas in
8 and medullary tumours of the adrenal in 2 rats.
Special controls.-Acetone painting ofthe genital tract failed to induce tumours
locally in intacts and castrates. The animals were killed when the experimental
groups had produced tumours or had died. The breast tumour in the intact group
(Table II) was a fibroadenoma. As the animals at death were much younger than
the general controls, tumours in the endocrine organs were not yet developed.
In the group treated with DMBA 4 times, the 2 breast tumours were adeno-
carcinomas, as was the uterine tumour. In addition, a squamous celled carcinoma
was found in the mandibular region, i.e. well outside the painted area.
The predominant lesion in the special controls with subcutaneous implants of
oestradiol was the purulent endometritis which gave rise to large pelvic andA. GLUCKSMANN AND CORA P. CHERRY
abdominal abscesses. In none of these animals was there any sign of carcino-
genesis in the genital tract.
Comments on the controls.-In animals born between 1954 and 1956 the inci-
dence of ileo-caecal lesions was fairly high and the disease was extensive, while
leukaemias were not found; in those born in 1964 the ileo-caecal lesion occurred
less frequently and ifpresent was in a much milder form. On the other hand, the
incidence of leukaemias was appreciable and clinically manifest between days 419
and 770. The same findings were made on control males born in 1954 and 1964
respectively: the incidence of ileo-caecal lesions decreased significantly over that
period, while that ofleukaemias increased.
The incidence of leukaemias in the experiments to be discussed in the present
report was much lower than in the controls born at about the same time in 1964.
This was due presumably to the fairly long latent period for leukaemias and the
much shorterinterval between DMBA-painting andtheinduction oftumoursin the
genital tract. Thus in the experiments begun in 1963 and lasting well into 1964
only 4 leukaemias were seen in 83 animals and in 1966 only 7 in 86 treated rats.
In other experiments, however, carried out at the same time and using L-thyroxin
or methylthiouracil as additional treatment, leukaemias occurred as early as 200
days after starting DMBA-painting, i.e. in rats aged 260 days.
Apart from the 2 adenocarcinomas ofthe uterus and the deciduoma, which are
outside the DMBA-treated region, no tumours in the cervico-vaginal tract were
found in either the general or special controls.
Experimental Animals
Epithelial tumours, as well as sarcomas, of the cervico-vaginal tract were
induced by DMBA-painting and their cumulative percentage increased linearly
with time. There were only minor and insignificant deviations from this line.
The induction period as well as the rate oftumour production differed for instance
between intact and castrate animals without further treatment. Though these
differences were statistically highlysignificant, to test whether the results remained
reproducible some of the fundamental experiments were repeated after intervals
of 4 to 10 years, occasionally with minor modifications. The results of such
repeat experiments are given in Table III. In intact rats painted once weekly
with DMBA in 1955 and in 1961, almost identical figures for the induction of
sarcomas were obtained. The difference in the incidence of sarcomas in castrates
painted once weeklywithDMBAin 1956andanothergroup in 1966 was statistically
TABLE III.-Cervico-Vaginal Tumours
Additional Stilboestrol Oestradiol
Treatment None None . None . None . per os i.m.
Date of starting 1955 1961 . 1956 1966 . 1960 1956
experiment 24/5 . 14/11 28/1 20/5 . 17/5 . 28/1
Number at risk . 23 l . 20 . 15g . 21 22 f . 16
Number with sarcomas . 16 . 15 3 6 . 5 . 5
Induction period (days)
for first . . 283 . 184 . 260 185 . 232 . 218
and last sarcoma . 381 . 380 . 406 . 315 . 338 . 396
Number with
epithelial tumours . 2 . 1 . 0 . 4 . 0 . 0
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not significant, though the tumours appeared slightly earlier in the repeat than the
original experiment. The incidence of papillomas in the second experiment was
also slightly higher. The third pair of experiments listed in Table III differed in
the form ofthe oestrogenic treatment: in 1956 the rats were injected twice weekly
with oestradiol (3,tg./week), while in 1960 they received per os about 2,tg./day
of stilboestrol in the drinking water. Again the results were surprisingly similar
as regards incidence of sarcomas and epithelial tumours. In fact the cumulative
percentage for sarcomas lies on practically the same line (Fig. 7).
For purposes of comparison, in the various graphs the two intact groups were
averaged and plotted and the same was done for the castrates.
Effects of castration and of hormonal treatments
Castration caused atrophy ofthe stroma ofthe vagina and uterus and quantita-
tive data about this reduction were given in a previous paper (Glucksmann and
Cherry, 1958). The vaginal epithelium was reduced to one to two layers of
mucus-secreting cuboidal or columnar cells. Normal tissues in animals in which
acetone or DMBA in acetone was applied to the vagina reacted alike to hormones
and differed in their morphology from similarly treated animals that were not
given hormones.
Stilboestrol induced a high cornifying vaginal and cervical epithelium in intact
animals, did not greatly affect the vaginal stroma, caused only slight hyperplasia
of the uterus and in less than 10 % of the rats treated with the higher dosage
(14,ug./week) produced a purulent endometritis. Squamous metaplasia of the
endometrial epithelium and glands was not observed, but a deciduoma was found
in one of the rats. In castrates the higher dosage of stilboestrol restored the
thickness of the vaginal stroma to that of intact animals, induced cornification in
the stratified vaginal and cervical epithelium, increased the uterine diameter to
intact size in 18 of 22 rats treated with the higher dosage and to about 90% normal
size in the remaining animals. With the lower dosage the uterus was only halfthe
normal size in 56 % of rats and three quarters in 44%. The vaginal and cervical
epithelium were of cornifying stratified type and the width of the vaginal stroma
was greater than in castrates.
Oestradiol at all 3 dosages in castrate rats restored the thickness ofthe vaginal
stroma to intact level, induced a high keratinising squamous epithelium in cervix
andvagina and enlargement ofthe uterus. The incidence ofsquamous metaplasia
in endometrial glands and epithelium increased with dosage from 6 % at 3,tg./week
to 65% at 35 ,tg./week. In castrate rats given 350 ,ug./week 54 % had squamous
metaplasia, while the epithelium in the rest was destroyed by an intense purulent
reaction. Inthe control rats ofthis group treated with a cholesterolpellet alonethe
castrate status of the vaginal stroma and epithelium and of the uterus was not
altered.
Progesterone given to intact animals did not change the thickness ofthe vaginal
stroma, induced mucification in a high columnar epithelium ofthe cervix while the
DMBA-treated vaginal epithelium was stratified. In about a third ofthe animals
the uterus was only 90 % of the normal size. The endometrial epithelium was
high and columnar, but the glands showed little development. In only 19 % of
castrate animals was the uterus restored to normal size, while the others remained
in the castrate state. Similarly the vaginal stroma remained of castrate type
and thickness.
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Testosterone administration to intact animals caused enlargement of the uterus
with high columnar epithelium and markedhyperplasia ofglands. In almost 50 %
of the treated rats evidence of squamous metaplasia in the endometrial glands or
the endometrial lining was found. The cervical epithelium tended to be of
columnar mucifying type, while DMBA-treated vaginal epithelium was stratified
and cornified. In castrate animals treatedwith testosteroneonly about 10 % had a
uterine diameter of normal size, while in the rest it was of castrate dimensions.
The vaginal stroma remained reduced in thickness. Additional treatment with
stilboestrol in the drinking water raised the proportion ofspayed rats with normal
sized uteri to 40 %, and also increased the thickness of the vaginal stroma. In
intact animals the combined treatment with stilboestrol and testosterone caused
hyperplasia of the uterus but to a lesser extent than did testosterone alone. Only
30 % of the animals showed squamous metaplasia of the endometrial glands and in
20 % there was some decidual reaction in the endometrial stroma. The cervical
epithelium tended to be ofthe columnar mucifying type.
In intact as well as castrate rats treated with testosterone as also in those given
additionally stilboestrol, the median tissue of the clitoris was transformed into a
calcified and in places ossified rod of fibrocartilage.
Castration caused hypertrophy of gonadotrophs and the appearance of castra-
tion cells in the pituitary followed later by the appearance of adenomas.
Stilboestrol by mouth, even when given continuously, failed to prevent the
formation ofcastration cells. In castrates treated with a subcutaneous oestradiol-
cholesterol pellet and in those given progesterone and oestradiol by injection, the
gonadotrophs were hypertrophic and hyperplastic but castration cells were not
found during the experiment. Progesterone alone did not prevent the occurrence
of castration cells. After testosterone treatment the castration cells were not as
prominent as after stilboestrol administration. The combined treatment with
testosterone and stilboestrol somewhat delayed the appeiarance of castration cells.
Though as comparedwith the castrate controls, theincidenceofpituitary adenomas
was reduced by oestrogenic and testosterone treatment, this effect was probably
due to the shorter survival period ofthe DMBA-treated animals as compared with
the controls as pituitary adenomas had a long induction period in castrate rats.
Testosterone treatment reduced the incidence of growing follicles and corpora
lutea and increased that of atretic structures. The other treatments did not
greatly affect the appearance of follicles and corpora lutea.
The induction ofcervico-vaginal tumours
Neither acetone painting alone nor the implantation of oestradiol pellets
induced any tumours in the cervico-vaginal tract. DMBA-painting was necessary
to elicit tumour formation which resulted in the formation of sarcomas in the
subepithelial vaginal tissue or of papillomas, intra-epithelial and invasive carci-
nomas ofthe vaginal or cervical epithelium. With weekly applications ofDMBA
EXPLANATION OF PLATES
FIG. 1 and 2. A cellular sarcoma of the vagina with giant cells induced in an intact rat
treated weekly with DMBA and 2 injections of Progestin per week. x 265 and x 680.
FIG. 3 and 4.-A leiomyosarcomatous component in a cellular sarcoma of the vagina in an
intact rat treated weekly with DMBA and 2 injections of Progestin per week. (a) normal
smooth muscle fibres. x 265 and x 680.
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for the duration of the life of the animals sarcomas were elicited more frequently
than epithelial tumours. The type ofsarcoma varied from a cellular fibrosarcoma
to giant celled sarcomas (Fig. 1, 2), leiomyosarcomas (Fig. 3, 4), myxofibro-
sarcomas and rhabdomyosarcomas or mixtures of the various components. The
type of sarcomas induced did not seem to be correlated with the additional
hormonal treatment and the spectrum of types was similar in all experiments.
The cancers spread locally and in the perineural lymphatics, and also invaded the
pelvic tissues as well as the vulva. Vascular emboli were seen not infrequently,
but distant metastases were not found and involvement of regional lymph nodes
was very rare. The epithelial tumours presented as squamous celled extruding or
80
Carcinomas + Papillomas
Sarcomas
60-
L 40/
20
100 200 300 400
D a y s
FIG. 5. Cumulative percentage of carcinomas plus papillomas and of sarcomas in castrate
rats treated weekly with DMBA and given intermittently stilboestrol per os (about 2-6, g./
week).
intruding papillomas, occasionally as carcinomas insitu (which are for the purposes
of the present paper included in the group of papillomas) and as invasive
carcinomas.
The proportion of sarcomas to epithelial tumours was affected by castration
and by various hormonal treatments, as was the duration of the induction period
and incidence of both types of tumours. Under certain experimental conditions
sarcomas as well as epithelial tumours were induced in the same rats at about the
same time and cumulative rate of incidence (Fig. 5).
The effect of castration and of sex hormones on the induction of sarcomas
Castration without additional hormonal treatment reduced the rate of tumour
formation (H20 thick and thin line in Fig. 6) to about one third of that in intact
rats, but did not alter the duration of the induction period in the most sensitive
animals. The cumulative percentage of sarcomas increased linearly with time inA. GLUCKSMANN AND CORA P. CHERRY
these as in all other experiments. The difference in tumour incidence between
intact and castrate rats was statistically significant and reproducible after an
interval of up to 10 years (Table III).
Oestrogen8 and cholesterol.-Stilboestrol given daily in the drinking water to
intact rats reduced the incidence ofsarcomas to the castrate level (Fig. 6), without
affecting the thickness ofthenormal stroma ofthevagina andwithoutreducingthe
size of the uterus (cf. above). Given for only 3 days a week, stilboestrol did not
alter the induction period or rate of sarcoma production in intact animals. In
castrates, stilboestrol administered daily or oestradiol given in 2 intramuscular
injections per week failed alike to raise the tumour incidence (Fig. 6 and 7) while
80
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FIG. 6.-Cumulative percentage of sarcomas induced in intact and castrate rats without
additional treatment (H20) or given stilboestrol in the drinking water continuously (7 x =
14pig./week) or on 3 consecutive days (3 x =2-6,sg./week) per os.
stilboestrol on 3 consecutive days a week greatly accelerated the appearance of
sarcomas. The first tumour occurred after 150 days as compared with 230 days
in intact rats without additional treatments (Fig. 6) and from that time on their
percentage increased linearly at the same rate as in intact rats without additional
treatment. The amount ofstilboestrol was not sufficient to restore to normal the
castrate status of the uterus and vaginal stroma or prevent the appearance of
castration cells in the pituitary.
Oestradiol monobenzoate intramuscularly in a dose of 3,ug./week equalled the
effect of 14,tg./week ofstilboestrol by mouth on tumour induction in castrate rats
(Fig. 7). Bigger doses given in the form ofsubcutaneous pellets ofpure oestradiol
(10 mg.) had the complication of eliciting a purulent endometritis, but failed to
increase the incidence of sarcomas from the castrate level and in fact lowered it.
Reduction of oestradiol dosage by combination of 1 mg. with 9 mg. of cholesterol
in a subcutaneous pellet raised the rate oftumour induction in spayed animals, but
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not to the same extent as did cholesterol alone inserted as a 10 mg. pellet (Fig. 7).
Progesterone.-The rate ofinduction ofsarcomas inintact rats was sloweddown
slightly by treatment with progesterone and not significantly increased in spayed
animals (Fig. 8). The combined treatment with progesterone and oestrogens of
castrate females prolonged theinduction period forthefirst sarcomas from 230days
for intact rats without additional treatments to 310 days, but subsequently the
tumours appeared at the same rate.
Testosterone.-In intact rats treated with testosterone the appearance of the
first sarcomas was delayed by 80 days, but the rate of cumulative percentage
80
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FIG. 7.-Cumulative percentage of sarcomas induced in castrate rats given stilboestrol per os
intermittently (3 x) or continuously (7 x), oestradiol i.m. (3,ug./week), oestradiol (as
subcutaneous pellet, 350,g./week), oestradiol-cholesterol (as subcutaneous pellet, 35,g./
week) and cholesterol alone (10 mg. pellet subcutaneously).
incidence was not altered (Fig. 9). In spayed animals treated with testosterone
the rate of tumour development was greatly increased over the castrate level, but
the induction period was not shortened. The testosterone effect on intact and
castrate animals was further delayed by additional treatment with stilboestrol
(Fig. 9).
The effect of castration and of sex hormones on the induction of epithelial tumours
The incidence of epitheial tumours and of carcinomas amongst them for the
various treatments is summarised in Table IV. The differences between intact
and spayed animals without additional treatments are hardly significant, though
invasive carcinomas occurred only in the intact group. Additional oestrogenic
treatment, with the exception ofthe intermittent administration ofstilboestrol to
castrate females, either did not affect the incidence of epithelial tumours or
suppressed them. The effect of additional treatments of intact and castrate rats
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FIG. 8.-Cumulative percentage of cervico-vaginal sarcomas induced in intact and castrate
rats given progesterone and stilboestrol alone or in combination.
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FIG. 9.-Cumulative percentage of cervico-vaginal sarcomas in intact and castrate rats given
testosterone and stilboestrol alone or in combination.
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TABLE IV.-Incidence of Cervico-Vaginal Carcinomas and Papillomas
Epithelial
Status Additional treatment No. ofrats tumours % Carcinomas %
9 . None . 43 . 7 . 2
g . None 36 . 11 . 0
* Stilboestrol 14 pzg. . 21 . 5 . 0
per os 6 pg. 21 . 10 . 0
14 ug. . 22 . 0 0
6,g. . 23 . 74 . 26
Oestradiol i.m. 3 pcg. . 16 . 0 0
Oestradiol s.c. 350 pzg. 11 . 0 0
Oestradiol 35 ug. . 20 . 0 . 0
+ cholesterol
Cholesterol . 17 . 35 . 6
Progesterone 21 34 . 5
27 0 . 0
+ Oestradioi . 21 5 0
Testosterone . 21 . 24 0
21 . 33 . 5
+ Stilboestrol . 20 . 20 . 0
20 . 14 . 0
with oestrogens and with progesterone on the incidence of epithelial tumours is
shown in Fig. 10. In addition the results of another experiment on the rate of
development of epithelial tumours in castrates given methylthiouracil in the
drinking water are illustrated for comparison. One group ofanimals was painted
weekly with DMBA 40 times and the other 20 times only. For the same period of
-0 40
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FIG. 10.-Cumulative percentage of epithelial tumours induced by DMBA in intact and
castrate rats given stilboestrol (continuously) or intermittently (3 x), or progesterone.
Shown are also some experiments in which the rats were given methylthiouracil per os
continuously but in which the weekly applications of DMBA were restricted to 20 and 40
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observation the rate of production of epithelial tumours was greater with the
restricted number of DMBA applications than with the larger number. The
incidence of sarcomas in these 2 groups was significantly higher with the more
frequent application ofDMBA. As shown in Fig. 5 the incidence ofboth sarcomas
and epithelial tumours was enhanced in castrates given stilboestrol per os inter-
mittently and the same promotion of sarcomas and epithelial tumours occurred
also in cholesterol-treated castrates. The low dose ofstilboestrol also favoured the
progression of epithelial tumours to the invasive stage (Table IV). Cholesterol
administration promoted the appearance of papillomas rather than of carcinomas
as did testosterone in castrate as well as intact rats. The testosterone effect was
reduced slightly by combined treatment with stilboestrol. In contradistinction
to the low stilboestrol dosage, the testosterone with and without stilboestrol,
progesterone or cholesterol administration failed to enhance significantly the
progression ofepithelial tumours to the invasive stage. Thus the proportion ofall
epitheliomas to carcinomas, excluding the low stilboestrol group for castrates, was
10*4 to 1 and 2-8 to 1 forthe latter group. The difference inthe rate ofprogression
of tumours was not due to a prolonged period of observation (Fig. 10) nor to a
reduction in the incidence of sarcomas in the animals. In the castrate group
treated intermittently with stilboestrol per os the incidence of sarcomas as well as
of epithelial tumours was greatly increased as compared with castrates without
additional treatment or castrates treated with higher doses of oestrogens.
Similarly treatment of castrates with cholesterol or testosterone promoted the
formation of sarcomas as well as of epithelial tumours (Fig. 7 and 9) while testo-
sterone or progesterone administration to intact rats prolonged the induction
period but did not affect the subsequent rate offormationofsarcomas (Fig. 8and 9).
DISCUSSION
The results ofexperiments on rats are reproducible, at least in our colony, with
remarkable accuracy even after long intervals. In mice of even the same strain
the results may vary considerably (Murphy, 1961, Tables IV and V for treatment
ofC3H mice with a MCA-thread only). Furthermore fewer rats than mice are lost
from accidental causes in our animal house and thus significant results are obtained
with smaller numbers.
Daily treatment with stilboestrol in addition to the weekly painting with
DMBA reduces the incidence of sarcomas in intact animals to the level ofcastrates,
but has no effect if given only on 3 consecutive days each week. As the animals
restrained their intake ofdrinking water for the first 2 of the 3 days, the effective
dosage may have been only a seventh instead of almost one half of that obtained
by the continuous administration ofstilboestrol. This small dose is very effective,
however, in increasing the rate of sarcoma induction in castrate rats and in
shortening the induction period to below that for intact animals. This indicates
that in intact animals the induction of sarcomas is not maximal, a conclusion
supported by the observations on rats treated additionally with cholesterol and
the previously reported acceleration ofsarcoma induction in castrate animals given
pelvic or whole body X-irradiation or adrenalectomised (Cherry and Glucksmann,
1960). Oestradiol monobenzoate injected twice weekly (3 ,tg./week) has the same
effect on castrate rats as the continuous addition of stilboestrol to the drinking
water. A pure pellet of oestradiol suppresses the induction of tumours, while
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addition of oestradiol to the cholesterol pellet retards the appearance of sarcomas
in castrate rats as compared with those given cholesterol only. A similar though
smaller retardation is seen in intact and spayed animnals given stilboestrol in the
drinking water in addition to testosterone administration as compared with
rats that had received testosterone only.
With the exception of the intermittent stilboestrol treatment in castrates, the
oestrogens either suppress or fail to change the incidence of epithelial tumours or
reduce it as compared with cholesterol treatment alone. The effect of a small
dose of stilboestrol on the induction of papillomas and carcinomas of the cervix
and vagina is, however, quite dramatic and is not achieved at the expense of the
appearance of sarcomas. In other as yet unpublished experiments, reducing the
number of weekly DMBA-paintings from about 40 to 20, 10 or only 5 diminishes
the incidence of sarcomas and increases that of epithelial tumours in castrate
animals whether or not treated additionally with thyroxin or methylthiouracil or
kept on ordinary drinking water. The optimum number of weekly paintings for
the induction of epithelial tumours is 10. The effect of oestrogenic treatment on
tumour induction is not paralleled by that on the normal epithelium and stroma
ofthe genital tract; the low stilboestrol dosage fails to restore to intact dimensions
the size of the uterus and the thickness of the vaginal stroma, whereas the larger
doses do and cause squamous metaplasia and pyometra. It is thus unlikely that
the effect on tumour formation is due directly to the hormonal influence of the
small stilboestrol dose; the disparity of action ofthe cholesterol pellet alone on the
normal tissues and tumours of the genital tract supports this view. Pyometra, if
anything, inhibits rather than promotes tumour formation contrary to Gardner
(1953) and Murphy (1961).
Progesterone retards and slightly decreases the induction of sarcomas, but
increases that of epithelial tumours in intact animals. The effect on both types
of tumours in castrates is not significant. In mice progesterones given singly or
combined with oestrogens do not affect the tumour yield (Blanzat, Hirai and
Pincus, 1966), while in castrates they may inhibit the appearance of carcinomas
and promote that of sarcomas (Kaslaris and Jull, 1962). The effect of proges-
terones on the type of induced cervical cancer in mice consists in increasing the
columnar component of mixed carcinomas in castrates (Glucksmann and Cherry,
1962) without materially affecting the induction period and tumour yield. Thus
the experimental evidence in rats and mice is not as clearly antitumorigenic as
that of Lipschutz (1950) for guinea pigs and the clinical observations (Ulfelder,
1962; Jolles, 1962).
In intact rats testosterones cause a marked hypertrophy of the endometrium,
its glands and of the stroma (Korenchevsky, Paris and Benjamin, 1950), and also
some squamous metaplasia in the endometrium and its glands. The appearance
of sarcomas is delayed, but not reduced as it is by continuous administration of
stilboestrol in the drinking water. Stilboestrol given in addition to testosterone
further delays the appearance of sarcomas but reduces the hypertrophy of the
normal uterus. Testosterone alone, and slightly less in combination with stilbo-
estrol, increases the incidence of papillomas. In castrates testosterone greatly
accelerates and increases the incidence of sarcomas and also that of epithelial
tumours though it has only a slight effect on the atrophic status of the uterus and
vaginal stroma. Additional treatment with stilboestrol increases the dimensions
of the castrate uterus to normal, but reduces the testosterone effect on the inci-
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dence of sarcomas as well as of epithelial tumours. In mice testosterone fails to
inhibit tumour induction in the cervix by oestrogenic treatment (Pan and Gardner,
1948), prolongs the induction period in DMBA-treated animals but less than
oestrogens (Meisels, 1964) and appears to inhibit the formation of carcinomas and
sarcomas in castrate mice implanted with a MC-thread (Kaslaris and Jull, 1962).
In Taki's (1967) short-term experiments testosterone and progesterone alike
appear to inhibit tumour formation in castrates.
Theinductionperiod for cervico-vaginal tumoursin ourexperimentsisrelatively
short in relation to that for mammary tumours particularly under the influence of
oestrogens (Gardner, 1953, Table 23) and also for the development of pituitary
adenomas. Thus the incidence of both these tumour types is not significant and
our experiments provide no evidence for a marked acceleration by the hormonal
treatments used. The effects on the pituitary (castration cells), on the breast,
the endometrium and uterine stroma by treatment with oestrogens, testosterone,
progesterone or cholesterol are not correlated with that on the induction of
cervico-vaginal tumours. Thus the influence on carcinogenesis is probably
distinct to some extent from the action of hormones on normal target tissues.
The effects ofoestrogens on tumour induction in mice differ from those in rats:
in rats oestrogens in doses sufficient to restore to normal the castrate status of the
uterus fail to promote carcinogenesis in spayed animals and even inhibit it in
intacts, while in mice the appearance of carcinomas increases with increasing
doses of oestrogens (Murphy, 1961). The difference may be due to different
sensitivities to oestrogens in the two species, as for mice variations in the response
tooestrogens ofdifferent strains are well known (Gardner, 1953, Table 21; Murphy,
1961). The type of induced tumour also differs: sarcomas predominate in rats
andepithelial tumours in mice. In mice some carcinogens induce sarcomas as well
as carcinomas (Kaslaris and Jull, 1962) while in rats reduction of the carcinogenic
dosage (Fig. 10) and hormonal treatments (Table IV) promote the appearance of
epithelial tumours. In mice (Taki, 1967) as in rats, cholesterol alone promotes the
formation of epithelial as well as sarcomatous tumours and the influence of
cholesterol on Murphy's results remains to be investigated. Because of different
absorption rates it is not possible to equate oestrogenic dosage in mice and rats
particularly for the prolonged treatment with subcutaneouspellets. In mice as in
rats ovariectomy renders the animals treated with limited or full doses of carcino-
gens more responsive to additional hormonal influences, partly because the rate of
tumour induction is almost maximal in intacts.
Inhibition of carcinogenesis by oestrogens in rats is found in salivary glands
(Glucksmann andCherry, 1966) as well as in the cervico-vaginal tract. Males have
a shorter induction period and faster rate than females of carcinoma and sarcoma
development in the salivary glands after injection with DMBA. In males the
tumour incidence is reduced by oestrogens while in females it is enhanced by
testosterone injections. Whether in man oestrogens as well as environmental
factors are responsible for the well known sex-linked differences in the incidence
oflung, tongue, laryngeal and stomach cancers remains to be investigated.
While the use ofoestrogens in the therapy of prostatic carcinoma in man can
be rationalised on hormonal grounds, the administration of oestrogens in the
treatment ofbreast cancers in women has no such clear cut endocrinological basis.
Oestrogens have more generalised effects than those on recognised target organs:
male rats injected repeatedly at intervals of 4 to 7 weeks gain weight more slowly
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than their controls or actually lose weight (Glucksmann and Cherry, 1968).
Oestrogens stimulate the reticulo-endothelial system and its immunological
responsiveness (Nicol, Vernon-Roberts and Quantock, 1965) and the development
ofthe cortical epithelial system ofthethymus (Cherry, Eisenstein andGlucksmann,
1967). They may be responsible for the fact that female rats as well as women of
the same genetic background tend to be smaller than their male counterparts.
It is not possible to state on the available evidence whether theinhibitory effects of
sufficiently large doses of oestrogens on carcinogenesis induced in the cervico-
vaginal tract ofrats are generalised growth inhibitory or indirect hormonal effects.
The experiments provide no evidence for any promotion of carcinogenesis linked
to the growth stimulating action ofoestrogens on the epithelium and stroma ofthe
female genital tract.
SUMMARY
(1) Castration reduces the rate of induction by DMBA of sarcomas in the
cervico-vaginal tract of rats.
(2) Oestrogens in doses sufficient to enlarge to normal size the castrate uterus
inhibit the formation ofsarcomas in intact rats and fail to promote that in castrate
animals. Small doses of stilboestrol per os, insufficient to restore to normal the
atrophy of the uterus, promote and accelerate the formation of sarcomas and of
epithelial tumours ofthe cervico-vaginal tract in castrate but not in intact rats.
(3) Progesterone in intact rats slightly retards the induction of sarcomas, but
promotes that ofpapillomas ofthe cervix and vagina. In castrates progesterone
fails to raise the rate of carcinogenesis ofepithelial and connective tissue tumours.
Combined with oestrogens, progesterone restores the rate of sarcoma formation to
the level ofintact rats, but prolongs the induction period.
(4) Testosterone lengthens the induction period for sarcomas in intact rats,
does not alterthe rate oftumourformation, andincreases theincidence ofepithelial
tumours. In castrates testosterone accelerates and increases the formation of
sarcomas and of epithelial tumours. The testosterone effects in intact and
castrate animals are reduced by combined administration with stilboestrol.
(5) Cholesterol increases the formation of sarcomas and epithelial tumours in
castrate rats and shortens the induction period without affecting the size of the
uterus.
(6) Epithelial tumours as well as sarcomas arise at about the same time and
rate in castrate animals given intermittently stilboestrol per os. The rate of
tumour formation is greater than that in intact animals without additional
treatments.
(7) The effect on carcinogenesis of oestrogens, progesterone, cholesterol and
testosterone is not correlated with the effect of these substances on the normal
tissues ofthe uterus, vaginal stroma or other target organs.
The authors are grateful to Dame Honor B. Fell, F.R.S. for reading the
manuscript and Mr. G. C. Lenney for the illustrations.
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